SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sherief R. Janmohamed, Gerard C. Madern, Peter C. J. de Laat, Arnold P. Oranje, Educational paper: therapy of infantile haemangioma—history and current state (part II), European Journal of Pediatrics, 2015, 174, 2, 259

    CrossRef

  2. 2
    Kristina Semkova, Jana Kazandjieva, Miroslava Kadurina, Nikolay Tsankov, Hemangioma Activity and Severity Index (HASI), an instrument for evaluating infantile hemangioma: development and preliminary validation, International Journal of Dermatology, 2015, 54, 4
  3. 3
    Gang Ma, Pinru Wu, Xiaoxi Lin, Hui Chen, Xiaojie Hu, Yunbo Jin, Yajing Qiu, Fractional Carbon Dioxide Laser–Assisted Drug Delivery of Topical Timolol Solution for the Treatment of Deep Infantile Hemangioma: A Pilot Study, Pediatric Dermatology, 2014, 31, 3
  4. You have free access to this content4
    M. Luu, I.J. Frieden, Haemangioma: clinical course, complications and management, British Journal of Dermatology, 2013, 169, 1
  5. 5
    S.R. Janmohamed, G.C. Madern, P.C.J. de Laat, A.P. Oranje, Hemangiomen en vasculaire malformaties, Tijdschrift voor Kindergeneeskunde, 2013, 81, 1, 14

    CrossRef

  6. 6
    Y. Qiu, G. Ma, J. Yang, X. Hu, H. Chen, Y. Jin, X. Lin, Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study, Clinical and Experimental Dermatology, 2013, 38, 8
  7. 7
    Klaske Nieuwenhuis, Peter C. J. de Laat, Sherief R. Janmohamed, Gerard C. Madern, Arnold P. Oranje, Infantile Hemangioma: Treatment with Short Course Systemic Corticosteroid Therapy as an Alternative for Propranolol, Pediatric Dermatology, 2013, 30, 1
  8. 8
    K. Semkova, J. Kazandjieva, Scoring the proliferative activity of haemangioma of infancy: state of the art, Clinical and Experimental Dermatology, 2013, 38, 1
  9. 9
    S. R. Janmohamed, F. B. de Waard-van der Spek, G. C. Madern, P. C. J. de Laat, W. C. J. Hop, A. P. Oranje, Scoring the proliferative activity of haemangioma of infancy: to HAS or not to HAS? Reply from author, Clinical and Experimental Dermatology, 2013, 38, 1
  10. 10
    M. de Graaf, M.F. Raphael, C.C. Breugem, M.J. Knol, C.A.F.M. Bruijnzeel-Koomen, M. Kon, J.M.P.J. Breur, S.G.M.A. Pasmans, Treatment of infantile haemangiomas with atenolol: Comparison with a historical propranolol group, Journal of Plastic, Reconstructive & Aesthetic Surgery, 2013, 66, 12, 1732

    CrossRef

  11. 11
    Sherief R. Janmohamed, Gerard C. Madern, Klaske Nieuwenhuis, Peter C. J. de Laat, Arnold P. Oranje, Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol, Pediatric Surgery International, 2012, 28, 4, 393

    CrossRef

  12. 12
    A.P. Oranje, S.R. Janmohamed, G.C. Madern, P.C.J. de Laat, Treatment of Small Superficial Haemangioma with Timolol 0.5% Ophthalmic Solution: A Series of 20 Cases, Dermatology, 2011, 223, 4, 330

    CrossRef